Price loading...

CRC Press Antiangiogenic Cancer Therapy

Name: Antiangiogenic Cancer Therapy
Brand: CRC Press

Oncology

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

Product Description Top Investigators Explore the Complexities of Angiogenesis Cancer Research The targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies. However, as of yet, no antiangiogenic agent used as a monotherapy has demonstrated a survival benefit in a randomized Phase III trial. The combination of bevacizumab, the first FDA approved angiogenesis inhibitor, with cytotoxic regimens has led to survival benefits in cancer patients. This has raised important questions about the complexities inherent in the clinical application of angiogenesis inhibitors. Compiles the results of four decades of progress Integrating fundamental concepts with therapeutic strategies, Anti-Angiogenic Cancer Therapy promotes the idea that an understanding of the molecular and cellular regulation of angiogenesis leads to optimal therapeutic strategies and positive clinical results. It brings together contributions from leading researchers to provide the most authoritative and encyclopedic volume available on this subject. Examines the role of angiogenesis in cancer, including strategies to prolong the nonangiogenic dormant state of human tumors, molecular mechanisms and cellular regulation of angiogenesis in solid tumors and hematologic malignancies, and the regulation of angiogenesis by the tumor microenvironment. Covers specific molecular targets for inhibiting angiogenesis in cancer therapy. Discusses clinical trial design and translational research approaches essential for identifying and developing effective angiogenesis inhibitors. Outlines current understanding of the molecular biology of each cancer type followed by discussions that examine strategies for targeting angiogenesis in specific cancers. This volume celebrates progress made in four decades, and more importantly, it provi About the Author Darren W. Davis, Roy S. Herbst, James L. Abbruzzese

Key Features

Used Book in Good Condition

Product Specifications

Brand: CRC Press
Format: hardcover
ASIN: 0849327997
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 25 July 2007
Listed Since: 01 February 2007

Barcode

No barcode data available

CRC Press Antiangiogenic Cancer Therapy

Price History & Forecast

No Price Data Available

Price Distribution

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

History of Research on Tumor Angiogenesis

Antiangiogenic Agents in Cancer Therapy (Cancer Drug Discovery and Development)

History of Research on Tumor Angiogenesis

Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy (Volume 18) (Cancer Sensitizing Agents for Chemotherapy, Volume 18)

Angiogenesis: From Basic Science to Clinical Applications

Anti-Angiogenesis Strategies in Cancer Therapies

Cardiovascular Complications in Cancer Therapy (Current Clinical Pathology)

Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy

Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy

Springer - Modeling Tumor Vasculature Academic Book

Stem Cells and Cancer (Cancer Drug Discovery and Development)

Chemistry and Pharmacology of Anticancer Drugs

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

Cardiovascular Toxicity and Therapeutic Modalities Targeting Cardio-oncology: From Basic Research to Advanced Study

Stem Cells and Cancer (Cancer Drug Discovery and Development)

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

The Tumor Microenvironment (Cancer Drug Discovery and Development)

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Anti-Angiogenic Functional and Medicinal Foods: 6 (Nutraceutical Science and Technology)

Humana PI3K-mTOR in Cancer and Cancer Therapy Book

Targeting Cell Survival Pathways to Enhance Response to Chemotherapy (Volume 3) (Cancer Sensitizing Agents for Chemotherapy, Volume 3)

Targeted Therapies in Oncology

Vascular Surgery in Oncology